Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc. Signs Another Contract to Implement Microsoft-Based Digital Prescription Software With Dr. Jacqueline Romero
Contract Follows Multiple New Contracts in Florida in Support of $10 Million 2008 Revenue Goal
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - April 24, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) announced today that the Company has signed a contract with Dr.
Jacqueline Romero of Oaktree Family Practice in Naples, Florida, to
implement the digiRX system and digiReauth call center services. Dr. Romero
received her license at the New York College of Osteopathic Medicine, New
York Institute of Technology, and she completed her residency at Palmetto
General Hospital.
digiRX and digiReauth are both proprietary, Microsoft-based applications
developed by digiMedical that provide digital prescription handling for
physicians, including prescription reauthorization processing and refill
management services. The applications are designed to more effectively
and efficiently move prescriptions digitally to company owned pharmacies to
be fulfilled for the patient.
Contract Follows Multiple Other Contracts Increasing Prescription Flow into
Company Pharmacies in the Region
Each new doctor contract can add hundreds of patients to the digiRX
network, who in turn drive prescription sales into company owned pharmacies
and increase company revenue. digiMedical owns and operates three
pharmacies in the Naples and Ft. Myers, Florida, area and Dr. Romero has
more than 2500 patients, seeing about 20 patients a day.
The Company is actively expanding their regional footprint in the Naples
area in support of the 2008 revenue goal of $10 million. This contract
follows digiMedical's recent announcements of other contracts with Drs.
Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon Dr. Howard
Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and Spilker of
the Collier Heart Group, the Medical Director of Vanish Vein and Laser
Center and Dr. Wey of the Neuroscience and Spine Associates in Naples,
Florida.
digiMedical Prescription Handling Software and Pharmacies
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
Recent Analyst Report Coverage with Recommendation of $0.30 or Higher
Micros Report initiated research coverage of digiMedical Solutions and
issued a report reviewing the Company's historical operations and 2008
business plan. Michael Willingham, Micros Report Director of Research,
authored the report which includes a Fair Value Target price for DGMS of
$0.30.
In the report, Mr. Willingham stated, "digiMedical's proprietary technology
solution positions the company to profit from both the traditional existing
pharmacy market space and the future of digital prescription fulfillment."
The report is available at http://www.digimedical.com/news/news.aspx under
"Featured Presentation." Interested parties may also access the report by
going to the www.MicrosReport.com homepage or by emailing
ir@digimedical.com and requesting a copy.
Company Information and Updates
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to receive more information on the company, please
send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc. ™
digiMedical Solutions, Inc.™ (http://www.digimedical.com) is a pharmacy
and medical technology company focused on developing next generation
digital medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'™ unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements'' for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate,'' "await,'' "envision,''
"foresee,'' "aim at,'' "believe,'' "intends,'' "estimates'' including
without limitation, those relating to the company's future business
prospects, are subject to certain risks and uncertainties that could cause
actual results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's filings
with the U.S. Securities and Exchange Commission for additional information
and a presentation of the risks and uncertainties that may affect the
company's business and results of operations.